2021, Volume 23, Issue 1
Strategic Study of CAE >> 2021, Volume 23, Issue 1 doi: 10.15302/J-SSCAE-2021.01.022
Development Strategy of Integrative Pharmacy
1. College of Pharmacy, Harbin Medical University, Harbin 150081, China;
2. Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, Harbin 150081, China;
3. State-Province Key Laboratory of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin 150081, China
Next Previous
Abstract
Integrative pharmacy is proposed owing to the increasingly profound understanding in complex diseases. It involves new drug research and development, innovation of traditional Chinese medicine, clinical practice of drugs, construction of the pharmacy discipline, cultivation of pharmaceutical professionals, and many other fields. To promote the practice of integrative pharmacy in China, this study clarifies the concept and connotation of integrative pharmacy and proposes future development strategies for integrative pharmacy. The research methods we used in this study includes literature research, academic exchange, and expert consultation. To integrate modern and traditional pharmacy, we suggest that clinical practice guidelines for integrative medication should be established and improved, innovative research of traditional Chinese medicine based on integrative thinking should be encouraged, and clinical application of Chinese and western medicine should be integrated and standardized. To promote the new drug research and development based on integrative pharmacy, the design idea of integrative drugs should be innovated, a drug evaluation system that adapts to integrative pharmacy should be developed,and a new drug development system should be established for integrative drugs. To promote the clinical application of integrative pharmacy, patient-centered clinical medication guidance should be further improved, individualized treatment should be encouraged, the clinical practice content of integrative pharmacy should be enriched, and the rational application of integrative drugs should be emphasized. To promote the construction of the integrative pharmacy discipline, the theoretical and practice curricula for undergraduate education should be enriched based on integrative pharmacy, and educational training and professional collaboration should be strengthened. Integrative pharmacy develops based on the theories and practices of modern pharmacy and integrates the theories and practices of all related disciplines of pharmacy. It is a new pharmacy theory and practice system that can promote human health and improve the existing medical system in China.
Keywords
integrative pharmacy ; integrative drugs ; new drug development ; drug evaluation ; clinical medication guidance
References
[ 1 ] Fan D M. The connotation and extension of holistic integrative medicine [J]. Medicine and Philosophy, 2017, 38(1): 7–13. Chinese. link1
[ 2 ] Fan D M. Re-discussion for holistic integrated medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 55–66. Chinese.
[ 3 ] Guo J, Chen G, Suo X B, et al. Holistic integrated pharmacy: A new era of pharmaceutical education [J]. Pharmaceutical Education, 2018, 34(3): 1–4. Chinese. link1
[ 4 ] Wu Y L. Theory of diagnosis and treatment of collateral disease and holistic integrative medical thinking [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 535–540. Chinese.
[ 5 ] Wang G J. There is much to be done in integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 529–534. Chinese.
[ 6 ] Li F. The future of integrative traditional Chinese medicine is bright [C]//Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 515–517. Chinese.
[ 7 ] Wu Y L, Chang L P. “Theory-clinical-new drug-experiment evidence-based” new model of traditional Chinese medicine [C]. Ji’nan: The 14th International Congress of Collateral Disease, 2018. Chinese.
[ 8 ] Yao D N, Hu H, Harnett J E, et al. Integrating traditional Chinese medicines into professional community pharmacy practice in China: Key stakeholder perspectives [J]. European Journal of Integrative Medicine, 2020, 34: 1–8. link1
[ 9 ] Tian X Y, Liu L. Drug discovery enters a new era with multi-target intervention strategy [J]. Chinese Journal of Integrative Medicine, 2012, 18(7): 539–542. link1
[10] Gu S, Pei J F. Chinese herbal medicine meets biological networks of complex diseases: a computational perspective [J]. Evidencebased Complementary and Alternative Medicine, 2017, 2017: 1–7. link1
[11] Wang Y, Fan X H, Qu H B, et al. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine [J]. Current Topics in Medicinal Chemistry, 2012, 12(12): 1356–1362. link1
[12] Chong C R, Sullivan D J. New uses for old drugs [J]. Nature, 2007, 448(7154): 645–646. link1
[13] Cui J M, Yin D L. Application and progress of drug repositioning in discovering new drugs [J]. Chinese Pharmaceutical Journal, 2005, 40(20): 1524–1526. Chinese. link1
[14] Boguski M S, Mandl K D, Sukhatme V P. Drug discovery repurposing with a difference [J]. Science, 2009, 324(5933): 1394–1395. link1
[15] Fan D M. Medicine and drug are teachers to each other [C]//Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 138–145. Chinese.
[16] Li J, Zheng S, Chen B, et al. A survey of current trends in computational drug repositioning [J]. Briefings in Bioinformatics, 2016, 17(1): 2–12. link1
[17] Seifirad S, Haghpanah V. Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine [J]. The EPMA Journal, 2019, 3(10): 195– 209. link1
[18] Cunha L, Horvath I, Ferreira S, et al. Preclinical imaging: An essential ally in modern biosciences [J]. Molecular Diagnosis & Therapy, 2014, 18(2): 153–173. link1
[19] Gatley S J, Volkow N D, Wang G J, et al. PET imaging in clinical drug abuse research [J]. Current Pharmaceutical Design, 2005, 11(25): 3203–3219. link1
[20] Chen K X. Creation of new drugs: Trends, challenges, and strategic thinking [J]. China Food & Drug Administration Magazine, 2015 (5): 24–25. Chinese. link1
[21] Fan D M. The rational use of drugs and reasonable medication [C]// Fan D M. Holistic integrative medicine: Theory & practice. Xi’an: World Publishing Corporation, 2016: 146–153. Chinese.
[22] Yang B F. My opinion on integrative medicine [C]// Fan D M. Holistic integrative medicine: Theory & practice③. Xi’an: World Publishing Corporation, 2018: 518–522. Chinese.
[23] Zuo H, Guo X X, Zhang K R. Individualized application of molecular-targeted drugs against cancer and new development for network medicine therapy [J]. Chinese Journal of New Drugs and Clinical Remedies, 2015, 34(5): 330–335. Chinese. link1
[24] Vonelstein B, Papadopoulos N, Velculescu V E, et al. Cancer genome landscapes [J]. Science, 2013, 339(6127): 1546– 1558. link1
[25] Zeng X, Jiang W Q, Yin W W, et al. Study on regional immune characteristics of early hepatocellular carcinoma based on single cell mass spectrometry [C]. Shanghai: The 13th National Academic Congress of Immunology, 2018. Chinese.
[26] Maher B. Exome sequencing takes center stage in cancer profiling [J]. Nature, 2009, 459(7244): 146–147. link1
[27] Angelo M, Bendall S C, Finck R, et al. Multiplexed ion beam imaging of human breast tumors [J]. Nature Medicine, 2014, 20(4): 436–442. link1
[28] Harnett J E, Ung C, Hu H, et al. Advancing the pharmacist’s role in promoting the appropriate and safe use of dietary supplements [J]. Complementary Therapies in Medicine, 2019, 44: 174–181. link1
京公网安备 11010502051620号
